AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kane Biotech Inc.

$0.02 -$0.01 (-30.08%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.02
Day Range
$0.02$0.02
Year Range
$0.01$0.03
Market Cap
3.81M
AVG Volume
115.48K
Trailing/Forward PE
-2.05/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2026-11-26
Primary Exchange
Other OTCUS
Revenue (CAD)
01M2M3M2016201720182019202020212022202320242025
KNBIF Revenue (CAD) by year
PeriodRevenue (CAD)
2025427.52K
20242.08M
20232.11M
20222.67M
20211.61M
20201.34M
20191.69M
2018506.59K
20171.04M
2016244.76K
Net Income (CAD)
-5M05M10M2016201720182019202020212022202320242025
KNBIF Net Income (CAD) by year
PeriodNet Income (CAD)
2025-2.72M
20246.1M
2023-4.74M
2022-3.89M
2021-4.6M
2020-3.72M
2019-960.18K
2018-3.26M
2017-2.79M
2016-2.55M
Operating Income (CAD)
-6M-4M-2M02016201720182019202020212022202320242025
KNBIF Operating Income (CAD) by year
PeriodOperating Income (CAD)
2025-3.11M
2024-3.92M
2023-4.01M
2022-3.36M
2021-4.88M
2020-4.22M
2019-3.59M
2018-3.18M
2017-2.69M
2016-2.43M
EBITDA (CAD)
-6M-4M-2M02016201720182019202020212022202320242025
KNBIF EBITDA (CAD) by year
PeriodEBITDA (CAD)
2025-2.95M
2024-3.71M
2023-3.59M
2022-2.82M
2021-4.25M
2020-3.65M
2019-3.38M
2018-3.05M
2017-2.63M
2016-2.38M
Cash Flows (CAD)
-6M-4M-2M02016201720182019202020212022202320242025
KNBIF Cash Flows (CAD) by year
PeriodCash Flows (CAD)
2025-3.26M
2024-4.2M
2023-3.27M
2022-3.14M
2021-2.64M
2020-4.07M
2019-1.05M
2018-3M
2017-2.26M
2016-2.63M
EPS (CAD)
-0.1-0.0500.052016201720182019202020212022202320242025
KNBIF EPS (CAD) by year
PeriodEPS (CAD)
2025-0.02
20240.04
2023-0.04
2022-0.03
2021-0.04
2020-0.03
2019-0.01
2018-0.04
2017-0.04
2016-0.08
Expenses (CAD)
02M4M6MR&DSG&ACapex2016201720182019202020212022202320242025
KNBIF Expenses (CAD) by year
PeriodExpenses (CAD)
20252.86M
20244.87M
20232.96M
20224.86M
20215.81M
20204.88M
20194.3M
20183.23M
20173.84M
20162.96M
Cash & Debt (CAD)
02.5M5M7.5M10MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
KNBIF Cash & Debt (CAD) by year
PeriodCash & Debt (CAD)
2025900.96K
2024358.81K
2023749.25K
20221.1M
20211.15M
20201.01M
2019834.13K
201875.42K
20171.98M
2016739.57K
Debt ratios
-0.6-0.4-0.2-00.220182019202020212022202320242025
KNBIF Debt ratios by year
PeriodDebt ratios
2025-0.11
2024-0.13
2023-0.59
2022-0.41
2021-0.25
2020-0.1
20190.06
2018-0.04
Margins
-50%0%50%100%2016201720182019202020212022202320242025
KNBIF Margins by year
PeriodMargins
2025-38.18%
202439.31%
20235.19%
202252.96%
202135.36%
202039.27%
201936.01%
201822.79%
201788.18%
201649.25%
Return on Capital
-400%-200%0%200%400%2016201720182019202020212022202320242025
KNBIF Return on Capital by year
PeriodReturn on Capital
2025364.51%
2024-374.28%
202356.42%
202294.01%
2021293.84%
2020-345.82%
2019-114.74%
2018331.12%
2017-101.76%
2016-189.15%
Shares Outstanding
050M100M150M200M2016201720182019202020212022202320242025
KNBIF Shares Outstanding by year
PeriodShares Outstanding
2025162.22M
2024141.98M
2023131.83M
2022124.83M
2021114.81M
2020108.62M
201986.15M
201864.09M
201788.87M
201645.54M
Book Value Per Share (CAD)
-0.08-0.05-0.03-00.020.052016201720182019202020212022202320242025
KNBIF Book Value Per Share (CAD) by year
PeriodBook Value Per Share (CAD)
2025-0
2024-0.01
2023-0.06
2022-0.03
2021-0.01
20200.01
20190.01
2018-0.02
20170.03
20160.03
Total Assets (CAD)
02M4M6M8M2016201720182019202020212022202320242025
KNBIF Total Assets (CAD) by year
PeriodTotal Assets (CAD)
20252.73M
20242.49M
20235.68M
20225.62M
20216.13M
20205.04M
20192.76M
20181.56M
20173.4M
20162.13M
PE Ratio
01234med 2.15Oct 24Dec 24Feb 25Apr 25Jun 25Aug 25Sep 25
KNBIF PE Ratio by year
PeriodPE Ratio
Sep 251.09
Sep 250.9
Sep 250.91
Sep 250.94
Aug 250.9
Aug 250.9
Aug 250.97
Aug 251
Aug 250.96
Jul 250.95
Jul 250.95
Jul 251.15
Jul 251.14
Jun 251.11
Jun 251.44
Jun 251.43
Jun 251.18
May 251.15
May 251.25
May 251.4
May 251.88
May 251.86
Apr 252.07
Apr 252.15
Apr 252.26
Apr 252.33
Mar 252.14
Mar 252.18
Mar 252.25
Mar 252.06
Feb 252.14
Feb 252.37
Feb 252.41
Feb 252.48
Jan 252.54
Jan 252.56
Jan 252.35
Jan 252.49
Jan 252.49
Dec 242.47
Dec 242.47
Dec 242.9
Dec 242.89
Nov 243.1
Nov 242.73
Nov 242.75
Nov 242.71
Nov 243.45
Oct 243.43
Oct 243.41
Oct 243.43
Oct 243.38
Free Cash Flow Yield
-80%-60%-40%-20%med -49.95%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
KNBIF Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-55.68%
Sep 26-61.99%
Aug 26-55.51%
Aug 26-47.36%
Aug 26-46.99%
Aug 26-58.87%
Jul 26-50.54%
Jul 26-55.97%
Jul 26-56.26%
Jul 26-56.05%
Jul 26-51.62%
Jun 26-71.85%
Jun 26-56.82%
Jun 26-57.43%
Jun 26-66.09%
May 26-66.81%
May 26-66.68%
May 26-60.9%
May 26-60.94%
May 26-44.66%
Apr 26-55.2%
Apr 26-68.55%
Apr 26-68.45%
Apr 26-65.59%
Mar 26-61.6%
Mar 26-62.38%
Mar 26-53.15%
Mar 26-51.19%
Feb 26-50.15%
Feb 26-50.02%
Feb 26-47.47%
Feb 26-46.47%
Jan 26-46.74%
Jan 26-44.21%
Jan 26-47.09%
Jan 26-49.26%
Jan 26-51.32%
Dec 25-50.25%
Dec 25-49.79%
Dec 25-49.89%
Dec 25-52.91%
Nov 25-52.32%
Nov 25-51.85%
Nov 25-49.37%
Nov 25-59.68%
Oct 25-45%
Oct 25-45.03%
Oct 25-44.95%
Oct 25-39.8%
Oct 25-39.95%
Sep 25-63.54%
Sep 25-77.12%
Sep 25-76.72%
Sep 25-74.12%
Aug 25-77.39%
Aug 25-76.93%
Aug 25-71.28%
Aug 25-69.24%
Aug 25-72.65%
Jul 25-73.13%
Jul 25-73.27%
Jul 25-60.65%
Jul 25-61.1%
Jun 25-61.82%
Jun 25-47.78%
Jun 25-48.32%
Jun 25-58.27%
May 25-60.01%
May 25-55.13%
May 25-49.28%
May 25-36.69%
May 25-37%
Apr 25-33.29%
Apr 25-32.07%
Apr 25-30.5%
Apr 25-29.55%
Mar 25-43.79%
Mar 25-43.03%
Mar 25-41.75%
Mar 25-45.47%
Feb 25-43.8%
Feb 25-39.65%
Feb 25-38.94%
Feb 25-37.93%
Jan 25-37.02%
Jan 25-36.6%
Jan 25-39.89%
Jan 25-37.68%
Jan 25-37.76%
Dec 24-45.18%
Dec 24-45.27%
Dec 24-38.49%
Dec 24-38.7%
Nov 24-36.06%
Nov 24-40.89%
Nov 24-40.66%
Nov 24-41.18%
Nov 24-32.39%
Oct 24-32.52%
Oct 24-32.74%
Price to Sales
0255075100med 7.47Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
KNBIF Price to Sales by year
PeriodPrice to Sales
Sep 2679.92
Sep 2671.79
Aug 2680.17
Aug 2693.96
Aug 2694.71
Aug 2675.59
Jul 2688.06
Jul 2679.51
Jul 2679.1
Jul 2679.4
Jul 2686.2
Jun 2610.61
Jun 2613.41
Jun 2613.27
Jun 2611.53
May 2611.4
May 2611.43
May 2612.51
May 2612.5
May 2617.06
Apr 2613.8
Apr 2611.12
Apr 2611.13
Apr 2611.62
Mar 268.86
Mar 268.75
Mar 2610.26
Mar 2610.66
Feb 2610.88
Feb 2610.91
Feb 2611.49
Feb 2611.74
Jan 2611.67
Jan 2612.34
Jan 2611.58
Jan 2611.07
Jan 2610.63
Dec 253.21
Dec 253.24
Dec 253.23
Dec 253.04
Nov 253.08
Nov 253.11
Nov 253.26
Nov 252.7
Oct 253.58
Oct 253.58
Oct 253.58
Oct 254.05
Oct 254.03
Sep 252.81
Sep 252.31
Sep 252.33
Sep 252.41
Aug 252.31
Aug 252.32
Aug 252.5
Aug 252.58
Aug 252.46
Jul 252.44
Jul 252.44
Jul 252.94
Jul 252.92
Jun 253.27
Jun 254.23
Jun 254.18
Jun 253.46
May 253.36
May 253.66
May 254.1
May 255.5
May 255.46
Apr 256.07
Apr 256.3
Apr 256.62
Apr 256.83
Mar 256.37
Mar 256.49
Mar 256.69
Mar 256.14
Feb 256.37
Feb 257.04
Feb 257.17
Feb 257.36
Jan 257.54
Jan 257.62
Jan 257
Jan 257.41
Jan 257.39
Dec 248.89
Dec 248.88
Dec 2410.44
Dec 2410.38
Nov 2411.15
Nov 249.83
Nov 249.88
Nov 249.76
Nov 2412.41
Oct 2412.36
Oct 2412.28
Price to Book
050100150med 25.52Jun 20Oct 20Jan 21Apr 21Aug 21Nov 21Sep 23
KNBIF Price to Book by year
PeriodPrice to Book
Sep 231.21
Sep 231.3
Sep 231.12
Sep 231.39
Aug 231.52
Aug 231.52
Aug 231.5
Aug 231.5
Jul 231.41
Jul 231.56
Jul 231.45
Dec 2158.02
Dec 2158.42
Dec 2157.04
Dec 2158.69
Nov 2163.65
Nov 2162.9
Nov 2159.43
Nov 2154.54
Oct 2158.85
Oct 2157.09
Oct 2160.53
Oct 2161.06
Oct 2166.04
Sep 2162.08
Sep 2162.5
Sep 2156.38
Sep 2157.71
Aug 2155.03
Aug 2158.19
Aug 2159.45
Aug 2158.81
Jul 2160.94
Jul 2161.17
Jul 2159.94
Jul 2158.08
Jul 2158.38
Jun 2116.16
Jun 2117.43
Jun 2117.77
Jun 2117.65
May 2119.11
May 2118.79
May 2119.53
May 2120.17
Apr 2122.32
Apr 2119.15
Apr 2118.82
Apr 2116.96
Apr 2117.15
Mar 218.85
Mar 218.19
Mar 217.26
Mar 217.48
Feb 217.36
Feb 216.95
Feb 217.25
Feb 216.67
Jan 216.95
Jan 217.3
Jan 217.22
Jan 217.89
Dec 207.88
Dec 20101.7
Dec 2097.52
Dec 20101.11
Dec 20102.67
Nov 20112.83
Nov 20102.66
Nov 20109.45
Nov 2089.37
Oct 2091.16
Oct 20104.19
Oct 20117.02
Oct 20106.6
Oct 20119.74
Sep 2027.23
Sep 2028.02
Sep 2027.97
Sep 2028.02
Aug 2026.64
Aug 2027.96
Aug 2026.19
Aug 2028.92
Jul 2025.85
Jul 2027.73
Jul 2029.05
Jul 2025.2
Jul 2021.84
Jun 2016.93
Jun 2017.87
Jun 2015.17
Jun 2014.14
May 2014.51
May 2014.57
May 2014.94
May 2014.23
May 2013.08
Apr 2013.42
Apr 2013.33
Kane Biotech Inc.
KNBIF
Stockpicker

Video analysis: KNBIF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KNBIF

Kane Biotech to Host Commercial Update Webcast on September 16

globenewswire.com · 9 Sep 2026

Kane Biotech to Host Commercial Update Webcast on September 16

Board Chair Philip Renaud, leading wound-care surgeon Dr. John C. Lantis and Interim CEO Dr. Robert Huizinga to discuss Kane's commercial progress, clinical relevance and operational priorities Board Chair Philip Renaud, leading wound-care surgeon Dr. John C. Lantis and Interim CEO Dr. Robert Huizinga to discuss Kane's commercial progress, clinical relevance and operational priorities

Kane Biotech Announces Second Quarter 2026 Financial Results

globenewswire.com · 27 Aug 2026

Kane Biotech Announces Second Quarter 2026 Financial Results

WINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its second quarter 2026 financial results.

Kane Biotech Announces Engagement of DNA Advisors

globenewswire.com · 5 Aug 2026

Kane Biotech Announces Engagement of DNA Advisors

DNA Advisors brings expertise in capital markets, strategic transactions, partnerships, and growth initiatives DNA Advisors brings expertise in capital markets, strategic transactions, partnerships, and growth initiatives

Kane Biotech Announces Results of Annual and Special Meeting of Shareholders

globenewswire.com · 2 Jul 2026

Kane Biotech Announces Results of Annual and Special Meeting of Shareholders

WINNIPEG, Manitoba, July 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) the voting results from its annual and special meeting of shareholders (the “Meeting”) on June 24, 2026.

Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript

seekingalpha.com · 24 Jun 2026

Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript

Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.